METABOLIC REPROGRAMMING OF PROSTATE CANCER AND ANTITUMOR IMMUNITY BY TARGETING LDH-A

$485,366FY2015Department of the ArmyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators